393 related articles for article (PubMed ID: 32014674)
1. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
2. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
3. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment.
Naito S; Yoshio T; Ishiyama A; Tsuchida T; Tokura J; Namikawa K; Tokai Y; Yoshimizu S; Horiuchi Y; Hirasawa T; Asari T; Mine S; Watanabe M; Ogura M; Chin K; Fukuzawa M; Itoi T; Fujisaki J
Dig Endosc; 2022 May; 34(4):793-804. PubMed ID: 34599604
[TBL] [Abstract][Full Text] [Related]
4. Endoscopic resection with adjuvant chemo-radiotherapy for superficial esophageal squamous cell carcinoma: A critical review.
Kam TY; Kountouri M; Roth A; Frossard JL; Huber O; Mönig S; Zilli T
Crit Rev Oncol Hematol; 2018 Apr; 124():61-65. PubMed ID: 29548487
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcomes of combined endoscopic resection and chemoradiotherapy for esophageal squamous cell carcinoma with submucosal invasion.
Yoshimizu S; Yoshio T; Ishiyama A; Tsuchida T; Horiuchi Y; Omae M; Hirasawa T; Asari T; Chin K; Fujisaki J
Dig Liver Dis; 2018 Aug; 50(8):833-838. PubMed ID: 29477349
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Endoscopic Resection and Selective Chemoradiotherapy for Stage I Esophageal Squamous Cell Carcinoma.
Minashi K; Nihei K; Mizusawa J; Takizawa K; Yano T; Ezoe Y; Tsuchida T; Ono H; Iizuka T; Hanaoka N; Oda I; Morita Y; Tajika M; Fujiwara J; Yamamoto Y; Katada C; Hori S; Doyama H; Oyama T; Nebiki H; Amagai K; Kubota Y; Nishimura K; Kobayashi N; Suzuki T; Hirasawa K; Takeuchi T; Fukuda H; Muto M
Gastroenterology; 2019 Aug; 157(2):382-390.e3. PubMed ID: 31014996
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic resection as an independent predictive factor of local control in patients with T1bN0M0 esophageal squamous cell carcinoma treated with chemoradiotherapy: a retrospective study.
Miyazaki T; Myojin M; Hosokawa M; Aoyama H; Okahara S; Takahashi H
Radiat Oncol; 2022 Jan; 17(1):11. PubMed ID: 35057830
[TBL] [Abstract][Full Text] [Related]
8. Best additional management after non-curative endoscopic resection of esophageal squamous cell carcinoma: a systematic review and meta-analysis.
Flor de Lima M; Castro B; Rodríguez-Carrasco M; Libânio D; Pimentel-Nunes P; Sousa O; Dinis-Ribeiro M
Scand J Gastroenterol; 2022 May; 57(5):525-533. PubMed ID: 34986068
[TBL] [Abstract][Full Text] [Related]
9. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
[TBL] [Abstract][Full Text] [Related]
10. Salvage endoscopic resection (ER) after chemoradiotherapy for esophageal squamous cell carcinoma: What are the risk factors for recurrence after salvage ER?
Hombu T; Yano T; Hatogai K; Kojima T; Kadota T; Onozawa M; Yoda Y; Hori K; Oono Y; Ikematsu H; Fujii S
Dig Endosc; 2018 May; 30(3):338-346. PubMed ID: 29106753
[TBL] [Abstract][Full Text] [Related]
11. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
[TBL] [Abstract][Full Text] [Related]
12. Additional Treatment Following Noncurative Endoscopic Resection for Esophageal Squamous Cell Carcinoma: A Comparison of Outcomes between Esophagectomy and Chemoradiotherapy.
Kanie Y; Okamura A; Asari T; Maruyama S; Sakamoto K; Fujiwara D; Kanamori J; Imamura Y; Ishiyama A; Yoshio T; Tsuchida T; Chin K; Watanabe M
Ann Surg Oncol; 2021 Dec; 28(13):8428-8435. PubMed ID: 34085140
[TBL] [Abstract][Full Text] [Related]
13. cT1N0M0 Esophageal Squamous Cell Carcinoma Invades the Muscularis Mucosa or Submucosa: Comparison of the Results of Endoscopic Submucosal Dissection and Esophagectomy.
Wang CY; Chen BH; Lee CH; Le PH; Tsou YK; Lin CH
Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053586
[TBL] [Abstract][Full Text] [Related]
14. Role of adjuvant chemoradiotherapy after endoscopic treatment of early-stage esophageal cancer: a systematic review.
Goense L; Meziani J; Borggreve AS; van Rossum PS; Meijer GJ; Ruurda JP; van Hillegersberg R; Weusten BL
Minerva Chir; 2018 Aug; 73(4):428-436. PubMed ID: 29658684
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the clinical outcomes of esophagectomy and chemoradiotherapy after noncurative endoscopic submucosal dissection for esophageal squamous cell carcinoma.
Koterazawa Y; Nakamura T; Oshikiri T; Kanaji S; Tanaka S; Ishida T; Yamashita K; Matsuda T; Morita Y; Suzuki S; Kakeji Y
Surg Today; 2018 Aug; 48(8):783-789. PubMed ID: 29532261
[TBL] [Abstract][Full Text] [Related]
16. Clinical Outcome of Additional Esophagectomy After Endoscopic Treatment for Superficial Esophageal Cancer.
Miyata H; Sugimura K; Kanemura T; Takeoka T; Yamamoto M; Shinno N; Hara H; Omori T; Yamamoto S; Ishihara R; Wada H; Takahashi H; Nishimura J; Matsuda C; Yasui M; Yano M
Ann Surg Oncol; 2021 Nov; 28(12):7230-7239. PubMed ID: 33959832
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
[TBL] [Abstract][Full Text] [Related]
18. Comparison of neoadjuvant chemotherapy versus upfront surgery with or without chemotherapy for patients with clinical stage III esophageal squamous cell carcinoma.
Matsuda S; Tsubosa Y; Sato H; Takebayashi K; Kawamorita K; Mori K; Niihara M; Tsushima T; Yokota T; Onozawa Y; Yasui H; Takeuchi H; Kitagawa Y
Dis Esophagus; 2017 Feb; 30(2):1-8. PubMed ID: 26919154
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of Superficial Esophageal Cancer: An Update].
Shin CM
Korean J Gastroenterol; 2021 Dec; 78(6):313-319. PubMed ID: 34955507
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcomes after non-curative endoscopic resection for esophageal squamous cell carcinoma followed by additional chemoradiotherapy.
Cho H; Abe S; Nonaka S; Suzuki H; Yoshinaga S; Okuma K; Yamamoto S; Daiko H; Kato K; Sekine S; Boku N; Saito Y
Dis Esophagus; 2024 Apr; 37(5):. PubMed ID: 38266034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
